McGowan BM, Bruun JM, Capehorn M, Pedersen SD, Pietilinen KH, Muniraju HAK, et al
Related incretin-based medicines you might hear about include tirzepatide (Mounjaro for type 2 diabetes, and Zepbound for chronic weight management), a dual GIP/GLP-1 receptor agonist given as a once-weekly injection
Patients with existing diabetic retinopathy or other retinal conditions should be monitored closely when starting GLP-1 agonists
Practice management software like Pabau, together with digital intake forms, helps practice teams capture complete, audit-ready documentation for every Z02.2 encounter
And even after people enroll, Milne wrote in an email to Undark, the substances short half-life would make it difficult for the researchers to ensure that participants are sticking with the trial protocol and not supplementing with gray market BPC-157